Table 2.
Baseline clinical characteristics of the study patients, based on the presence of visceral obesity.
| Parameter | Patients with visceral obesity, n = 54 | Patients without visceral obesity, n = 30 | p |
|---|---|---|---|
| Mean age (range), years | 58.5 (53; 63) | 56 (51.5;63.5) | 0.71 |
| Male gender, n (%) | 45 (83.3) | 20 (66.7) | 0.613 |
| Mean BMI (range), kg/m2 | 28.7 (17.1;39.1) | 25.9 (18.3;38.4) | 0.005 |
| Characteristic adipose tissue distribution | |||
| Abdominal fat area, cm2 | 541 (381;725) | 357 (253;623) | 0.00 |
| VAT area (range), cm2 | 197(145;301) | 108 (64;124) | 0.00 |
| SAT area (range), cm2 | 316 (201;501) | 253 (159;498) | 0.00 |
| VAT/SAT | 0.62 (0.60;0.72) | 0.43 (0.24;0.50) | 0.00 |
| Risk factors | |||
| Documented arterial hypertension, n (%) | 54 (100.0) | 29 (96.7) | 0.207 |
| Smoking, n (%) | 33 (61.1) | 12 (40.0) | 0.109 |
| Hypercholesterolemia, n (%) | 43 (79.6) | 20 (66.7) | 0.25 |
| Prior myocardial infarction, n (%) | 11 (20.4) | 6 (20.0) | 0.21 |
| PCI | 11 (20.4) | 6(20.0) | 0.12 |
| Stroke | 5 (9.3) | 2 (6.7) | |
| Angina | 45 (83.3) | 22 (73.3) | 0.23 |
| Percutaneous coronary intervention | 11(20.4) | 6 (20.0) | 0.12 |
| Coronary artery bypass surgery | 2 (3.7) | ||
| CHF | |||
| CHF I | 14 (25.9) | 9 (30.0) | 0.17 |
| CHF IIA-B | 6 (11.1) | 4 (13.3) | 0.74 |
| CHF III | – | – | – |
BMI, Body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; CHD, coronary heart disease; CHF, congestive heart failure.